Request a document copy: Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

all files (of this document) in restricted access
the file(s) you requested
Cancel